Blood and bone marrow dosimetry in radioiodine therapy of thyroid cancer

被引：0
|
作者：
Sgouros, G [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD 21218 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2005年 / 46卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：899 / 900
页数：2
相关论文
共 50 条
  • [1] Blood and bone marrow dosimetry in radioiodine therapy of differentiated thyroid cancer after stimulation with rhTSH
    Lassmann, M
    Hänscheid, H
    Reiners, C
    Thomas, SR
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2005, 46 (05) : 900 - 901
  • [2] Blood and bone marrow dosimetry in radioiodine therapy of differentiated thyroid cancer after stimulation with rhTSH - Reply
    de Keizer, B
    de Klerk, JMH
    Konijnenberg, MW
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2005, 46 (05) : 901 - 901
  • [3] Correlation between pretherapeutic blood dosimetry with iodine-124 and bone marrow toxicity after radioiodine therapy of differentiated thyroid carcinoma
    Hartung, V.
    Jentzen, W.
    Freudenberg, L.
    Bockisch, A.
    Stahl, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S266 - S266
  • [4] Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer
    Pacilio, Massimiliano
    Conte, Miriam
    Frantellizzi, Viviana
    De Feo, Maria Silvia
    Pisani, Antonio Rosario
    Marongiu, Andrea
    Nuvoli, Susanna
    Rubini, Giuseppe
    Spanu, Angela
    De Vincentis, Giuseppe
    [J]. DIAGNOSTICS, 2022, 12 (07)
  • [5] Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer
    Lassmann, M
    Luster, M
    Hänscheid, H
    Reiners, C
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2005, 46 (05) : 899 - 899
  • [6] Radioiodine dosimetry in advanced thyroid cancer
    Giovanella, Luca
    Lassmann, Michael
    [J]. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 63 (03): : 227 - 228
  • [7] Preliminary results of pretherapeutic blood and bone marrow dosimetry of patients with differentiated thyroid cancer
    Kalathas, T.
    Mitsakis, P.
    Kotzassarlidou, M.
    Hatzipavlidou, V.
    Raptou, E.
    Salem, N.
    Makridou, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S437 - S437
  • [8] Dosimetry during radioiodine therapy in metastatic differentiated thyroid cancer.
    Castellani, M. R.
    Chiesa, C.
    Botta, F.
    Azzeroni, R.
    Negri, A.
    Mansi, D.
    Maccauro, M.
    Orunesu, E.
    Seregni, E.
    Bombardieri, E.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S417 - S417
  • [9] Bone marrow suppression in pediatric patients with differentiated thyroid cancer following empirical radioiodine therapy
    Dong, Ping
    Wang, Li
    Huang, Rui
    Li, Lin
    [J]. MEDICINE, 2020, 99 (31)
  • [10] EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy
    Michael Lassmann
    Heribert Hänscheid
    Carlo Chiesa
    Cecilia Hindorf
    Glenn Flux
    Markus Luster
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35
12345